1. Osteoporosis in chronic liver disease

   • Jenny Heathcote

   Invited Commentary Pages: 455 - 458

2. Web alert

   News Pages: 459 - 460

3. Literature alert

   Abstract Pages: 461 - 463

4. Evolutionary biologic therapy for inflammatory bowel disease

   • Stephen B. Hanauer

   Clinical Trials Review Pages: 467 - 469

5. New biologic agents: A critical appraisal

   • Bruce E. Sands

   OriginalPaper Pages: 470 - 475

6. Prevention of postoperative recurrence in Crohn’s disease

   • Geert D’Haens

   OriginalPaper Pages: 476 - 481

7. Serologic testing in inflammatory bowel disease: Its value in indeterminate colitis

   • Konstantinos A. Papadakis
   • Stephan R. Targan

   OriginalPaper Pages: 482 - 485

8. Cyclosporine in inflammatory bowel disease

   • Asher Kornbluth

   OriginalPaper Pages: 486 - 490

9. Genetic aspects of inflammatory bowel disease: How far have we come, and where are we heading?

   • Judy Cho

   OriginalPaper Pages: 491 - 495

10. Cancer surveillance in inflammatory bowel disease

    • Charles N. Bernstein

    OriginalPaper Pages: 496 - 504

11. Proton pump inhibitors and H. pylori infection: Why the concern?

    • Wilfred M. Weinstein

    Clinical Trials Review Pages: 507 - 510

12. The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach

    • Joseph R. Pisegna

    OriginalPaper Pages: 511 - 517

13. Therapy for H. pylori infection

    • Alan B. R. Thomson

    OriginalPaper Pages: 518 - 523